A detailed history of Black Rock Inc. transactions in Novartis Ag stock. As of the latest transaction made, Black Rock Inc. holds 1,858,800 shares of NVS stock, worth $192 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,858,800
Previous 1,829,523 1.6%
Holding current value
$192 Million
Previous $185 Million 2.67%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$95.27 - $108.47 $2.79 Million - $3.18 Million
29,277 Added 1.6%
1,858,800 $180 Million
Q4 2023

Feb 13, 2024

BUY
$92.27 - $101.54 $9.74 Million - $10.7 Million
105,587 Added 6.12%
1,829,523 $185 Million
Q3 2023

Nov 13, 2023

SELL
$94.73 - $105.13 $101,455 - $112,594
-1,071 Reduced 0.06%
1,723,936 $176 Million
Q2 2023

Aug 11, 2023

BUY
$92.52 - $104.91 $9.9 Million - $11.2 Million
106,966 Added 6.61%
1,725,007 $174 Million
Q1 2023

May 12, 2023

BUY
$80.03 - $92.81 $6.87 Million - $7.97 Million
85,903 Added 5.61%
1,618,041 $149 Million
Q4 2022

Feb 13, 2023

BUY
$75.55 - $92.52 $10.6 Million - $13 Million
140,569 Added 10.1%
1,532,138 $139 Million
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $11.5 Million - $13.4 Million
-153,713 Reduced 9.95%
1,391,569 $106 Million
Q2 2022

Aug 12, 2022

SELL
$80.52 - $93.75 $906,413 - $1.06 Million
-11,257 Reduced 0.72%
1,545,282 $131 Million
Q1 2022

May 12, 2022

BUY
$80.11 - $90.62 $19.3 Million - $21.8 Million
240,710 Added 18.29%
1,556,539 $137 Million
Q4 2021

Feb 10, 2022

SELL
$79.7 - $88.13 $6.05 Million - $6.69 Million
-75,861 Reduced 5.45%
1,315,829 $115 Million
Q3 2021

Nov 09, 2021

SELL
$81.78 - $95.14 $4 Million - $4.65 Million
-48,877 Reduced 3.39%
1,391,690 $114 Million
Q2 2021

Aug 11, 2021

BUY
$85.24 - $94.15 $123 Million - $136 Million
1,440,567 New
1,440,567 $131 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.